Probiotic Visbiome improves gut barrier function in patients with HIV
“Probiotic supplementation improved the physical and immunological integrity of the intestinal mucosal barrier in HIV-1-positive patients being treated with antiretroviral therapy, according to new research. The researchers sought to evaluate the effects of a high potency multistrain probiotic — marketed in the U.S. as Visbiome (ExeGi Pharma) and Vivomixx in Europe — on intestinal …
Probiotic Visbiome improves gut barrier function in patients with HIV Read More »